Shopping Cart
- Remove All
- Your shopping cart is currently empty
B026 is a selective, orally active inhibitor of p300/CBP histone acetyltransferase (p300/CBP HAT) that acts on p300 (IC50: 1.8 nM) and CBP (IC50: 9.5 nM). b026 exhibits anticancer effects on androgen receptor positive (AR+) prostate cancer cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,140 | 10-14 weeks | |
50 mg | $2,785 | 10-14 weeks | |
100 mg | $3,520 | 10-14 weeks |
Description | B026 is a selective, orally active inhibitor of p300/CBP histone acetyltransferase (p300/CBP HAT) that acts on p300 (IC50: 1.8 nM) and CBP (IC50: 9.5 nM). b026 exhibits anticancer effects on androgen receptor positive (AR+) prostate cancer cells. |
Molecular Weight | 557.5 |
Formula | C27H23F4N5O4 |
Cas No. | 2379416-48-3 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.